Apitoria Pharma Pvt Ltd receives 3 observations from USFDA for Unit-V

The United States Food and Drug Administration (US FDA) inspected Unit-V, an API manufacturing facility, of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company, situated at Industrial Development Area, Chemical Zone, Pashamylaram Village, Patancheru Mandal, Sangareddy District, 502307, Telangana from December 01 to December 12, 2025.

At the end of the current inspection, a 'Form 483' was issued with 03 observations which are procedural in nature, and we will respond to the US FDA within the stipulated timelines.

The Company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1193.70 as compared to the previous close of Rs. 1172.50. The total number of shares traded during the day was 12937 in over 1070 trades.

The stock hit an intraday high of Rs. 1199.40 and intraday low of 1169.65. The net turnover during the day was Rs. 15382975.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 Pharmaceuticals ApitoriaPharma UnitV APIManufacturingFacility USFDA Inspection Form483 3Observations